BioArctic AB (publ) (STO:BIOA.B)
322.00
-23.00 (-6.67%)
Aug 26, 2026, 5:29 PM CET
BioArctic AB Revenue
BioArctic AB had revenue of 247.53M SEK in the quarter ending June 30, 2026, a decrease of -36.88%. This brings the company's revenue in the last twelve months to 1.00B, down -46.09% year-over-year. In the year 2025, BioArctic AB had annual revenue of 2.00B with 676.80% growth.
Revenue (ttm)
1.00B
Revenue Growth
-46.09%
P/S Ratio
28.50
Revenue / Employee
7.11M
Employees
141
Market Cap
28.57B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.00B | 1.74B | 676.80% |
| Dec 31, 2024 | 257.35M | -358.64M | -58.22% |
| Dec 31, 2023 | 616.00M | 386.56M | 168.49% |
| Dec 31, 2022 | 229.43M | 203.77M | 794.02% |
| Dec 31, 2021 | 25.66M | -39.54M | -60.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Camurus AB | 2.27B |
| Saniona AB | 429.29M |
| BioInvent International AB | 217.86M |
| Hansa Biopharma AB | 189.46M |
| Genovis AB (publ.) | 136.99M |
| Egetis Therapeutics AB | 66.00M |
| Medivir AB | 8.41M |
| Vicore Pharma Holding AB | 3.99M |
BioArctic AB News
- 18 hours ago - BioArctic AB Earnings Call Transcript: Q2 2026 - Transcripts
- 18 hours ago - BioArctic AB Quarterly report: Q2 2026 - Filings
- 18 hours ago - BioArctic AB Slides: Q2 2026 - Filings
- 19 hours ago - BioArctic: Interim Report for the period April - June 2026 - PRNewsWire
- 2 days ago - Leqembi Iqlik® for initiation treatment launched in the US - PRNewsWire
- 7 days ago - BioArctic and Mesenkia enter oncology research collaboration - PRNewsWire
- 7 days ago - Invitation to presentation of BioArctic's second quarter report for April - June 2026 on August 26 at 9:30 a.m. CEST - PRNewsWire
- 4 weeks ago - Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026 - PRNewsWire